Boston Scientific Names Joseph M. Fitzgerald Chief Operating Officer

Boston Scientific Corp. has appointed Joseph M. Fitzgerald as executive vice president and chief operating officer, effective Jan. 1, 2027, according to Medical Product Outsourcing.

The announcement identifies Fitzgerald as the company’s incoming chief operating officer and sets a future effective date for the executive leadership change.

Executive appointment reported

Medical Product Outsourcing reported that Boston Scientific named Fitzgerald to the dual roles of executive vice president and chief operating officer. The reported appointment is scheduled to take effect on Jan. 1, 2027.

The supplied report names Boston Scientific Corp., Joseph M. Fitzgerald, the executive vice president title, the chief operating officer role, and the effective date. It does not provide additional details on responsibilities, reporting relationships, commercial strategy, or organizational changes.

Leadership development for medical device professionals

For medical device sales and commercial leaders tracking executive developments, the appointment is a reported change within Boston Scientific’s senior leadership structure. Medical Product Outsourcing described Fitzgerald’s planned role as executive vice president and chief operating officer.

The effective date places the change in 2027 rather than at the time of the report. Professionals following the company can distinguish between the announcement of the appointment and the date on which the appointment is reported to become effective.

What the supplied report confirms

• Boston Scientific Corp. appointed Joseph M. Fitzgerald.
• Fitzgerald will serve as executive vice president and chief operating officer.
• The appointment is effective Jan. 1, 2027.
• Medical Product Outsourcing published the report.

No further information about the transition was included in the supplied evidence.